---
title: "Rachel Bito, M.D. | Sutter Health"
url: "https://www.sutterhealth.org/research/investigators/rachel-bito-md-2070392186"
---

1.  [Home](https://www.sutterhealth.org/) /
2.  [Research](https://www.sutterhealth.org/research) /
3.  [Investigators](https://www.sutterhealth.org/research/investigators) /
4.  Rachel Bito, M.D.

![Rachel Bito, M.D.](https://dyn.mktgcdn.com/p/em5BCfKmxDdoti4IT452AsRnu4kiCH6uukzlEK-voe0/fit=crop,gravity=auto,dpr=2,width=240,height=240)

# Rachel Bito, M.D.

Investigator

[View profile](https://www.sutterhealth.org/find-provider/dr-rachel-bito-2057384138)

## Clinical trials

-   Clinical trial
    
    ### [Cancer Young Female Adults Ovarian Damage Prevention ALTE2131](https://www.sutterhealth.org/research/clinical-trials/cancer-young-female-adults-ovarian-damage-prevention-alte2131-2027477841)
    
    Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Neoadjuvant Hodgkin Lymphoma COG AHOD2131](https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-hodgkin-lymphoma-cog-ahod2131-2080025103)
    
    A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Neoadjuvant Neuroblastoma ANBL2131](https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-neuroblastoma-anbl2131-2022194957)
    
    A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Neoadjuvant Pediatric Leukemia AALL1821](https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-pediatric-leukemia-aall1821-1049141818)
    
    A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse.
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Pediatric B-Lymphoblastic Leukemia COG AALL1732](https://www.sutterhealth.org/research/clinical-trials/cogaall1732-1049141808)
    
    A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLyLy
    
    **Status:** Open to Enrollment
    

Page 1 of 2

```json
{"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]}
```

```json
{"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/investigators/rachel-bito-md-2070392186#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Investigators","item":"https://www.sutterhealth.org/research/investigators"},{"@type":"ListItem","position":4,"name":"Rachel Bito, M.D."}]}
```

```json
{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://www.sutterhealth.org/research/investigators/rachel-bito-md-2070392186#profilepage","url":"https://www.sutterhealth.org/research/investigators/rachel-bito-md-2070392186","name":"Rachel Bito, M.D.","dateModified":"2026-06-25","breadcrumb":{"@id":"https://www.sutterhealth.org/research/investigators/rachel-bito-md-2070392186#breadcrumblist"},"primaryImageOfPage":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/em5BCfKmxDdoti4IT452AsRnu4kiCH6uukzlEK-voe0/460x460.webp","width":460,"height":460},"mainEntity":{"@id":"https://www.sutterhealth.org/research/investigators/rachel-bito-md-2070392186"}}
```

```json
{"@context":"https://schema.org","@type":"Person","@id":"https://www.sutterhealth.org/research/investigators/rachel-bito-md-2070392186","name":"Rachel Bito, M.D.","givenName":"Rachel","familyName":"Bito","honorificSuffix":"M.D.","image":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/em5BCfKmxDdoti4IT452AsRnu4kiCH6uukzlEK-voe0/460x460.webp","representativeOfPage":true},"affiliation":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"mainEntityOfPage":{"@id":"https://www.sutterhealth.org/research/investigators/rachel-bito-md-2070392186#profilepage"},"sameAs":"https://www.sutterhealth.org/find-provider/dr-rachel-bito-2057384138"}
```